Green Cross Corp

Activities: Manufacturing Research & Development Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical

A bullish time for biotech

Biotechnology has changed healthcare radically over the past decade and its impact on the pharmaceutical sector is growing. Susan Birks reports on the impact of the biotech boom
Design & Build

Green Cross Biotherapeutics begins construction in Montreal

The CA$315m biopharmaceutical facility will employ 200 professionals
Pharmaceutical

Green Cross and Nanolek agree partnership for biologics commercialisation in Russia

Nanolek will license the technology and manufacture a number of biologics for Green Cross
Finance

Green Cross expands cell therapy business in China

Company to build a cell therapy facility in the southwestern Chinese province to produce and distribute cell therapy products in China
Manufacturing

PBS Biotech signs up GCMS as bioreactor distributor in Korea

Offers Korean biopharmas technology to produce drugs, vaccines and biosimilars for global market
Subscribe now